Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.

scientific article published in June 1998

Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9626465

P2093author name stringHarada M
Tashiro S
Fukuda Y
Izumi K
Sano N
Miyake H
Mise K
Wada D
Yogita S
Isikawa M
P433issue6
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)1475-1482
P577publication date1998-06-01
P1433published inClinical Cancer ResearchQ332253
P1476titleAssessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis
P478volume4

Reverse relations

cites work (P2860)
Q36092123Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis
Q83956863Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma
Q43201114Detection of HBV, PCNA and GST-pi in hepatocellular carcinoma and chronic liver diseases
Q40585730Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters
Q58602183Dimensions of hepatocellular carcinoma phenotypic diversity
Q40603982Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells.
Q36694298Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
Q35364363Genomic homogeneity in fibrolamellar carcinomas
Q43148137Liver stem cells and molecular signaling pathways in hepatocellular carcinoma
Q38280688Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis
Q46151710TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis
Q36615203TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma
Q34668320The prognostic molecular markers in hepatocellular carcinoma

Search more.